Loading the company…
Loading the company…
Families: Cervical fusion & disc arthroplasty, Lumbar fusion, SI joint fusion.
All companies · Product and company coverage
In the last ten years FDA made 12 decisions for Curiteva (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2018 (4). The latest was on 2026-01-16.
| Family | Decisions on record |
|---|---|
| Cervical fusion & disc arthroplasty | 7 |
| Lumbar fusion | 7 |
| SI joint fusion | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-01-16 | 510(k) | K252205 | Curiteva Porous PEEK Cervical Interbody System; Curiteva Porous PEEK Lumbar Interbody System; Curiteva Porous PEEK Laminoplasty System; Curiteva Porous PEEK Standalone ALIF System |
| 2026-01-15 | 510(k) | K254061 | Curiteva Porous PEEK Cervical Interbody Fusion System |
| 2025-06-18 | 510(k) | K250845 | Curiteva Porous PEEK Standalone ALIF System |
| 2024-02-29 | 510(k) | K233360 | Curiteva Thoracolumbar Plate System |
| 2024-01-18 | 510(k) | K233744 | Curiteva Porous PEEK Lumbar Interbody Fusion System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Curiteva.